A B S T R A C T The addition of apoprotein E isolated from human very low density lipoproteins to both rat lymph chylomicrons and a triglyceride emulsion significantly increased the hepatic uptake of these particles in a nonrecycling isolated rat liver perftision system. The cleared triglyceride was removed without apparent hydrolysis by the hepatocyte. When lymph chylomicrons were loaded with both Apo E and Apo C proteins by exposture to rat plasma, no increment in hepatic clearance was observed. Sequential evaluations of the influence of the C apoproteins on the hepatic clearance of both emulsions an(l chylomicrons revealed that the CIII (CIII-1) protein had a pronounced inhibitory effect on hepatic removal. The inhibition was observed for both Apo E-enriched chylomicrons and those containing little of this apoprotein.
INTRODUCTION
Unmetabolized triglyceride-rich chylomicrons appear to be poorly removed by the liver (1) . The bulk of the triglyceride in the particle is distributed to peripheral tissues and the cholesterol that remains after this metabolism returns to the liver. When the liver is directly perfiused with either lymph-or plasma-exposed chvlomicrons, some observers (1) have noted virtually nio removal of the particles whereas others have seen some uptake (2, 3) . However, after the lymph chylonmicrons are metabolized by peripheral tissues, the liver appears to actively clear the remnants (4) . It has been speculated (5) that the metabolized chylomicron contains some lipoprotein lipase which, in turn, changes its affinity for the hepatocyte. However, there is curreiitly no mechanism to explain why the lymph-or plasma-exposed chylomicrons enter the liver, whereas the remnant chylomicron is briskly removed (6) . The METHODS Preparation of the chylomiiicron and synthetic emulsion: chvlomicrons were obtained from a mesenteric lymph-fistulize'd Sprague-Dawley rat by a modification of the technique of Bollman et al. (8) . Animals were fed a corn oil diet containing (9) containing 3 g/dl of bovine albumin (Reheis Co., Inc., Phoenix, Ariz.) and 2% glycerin. The albumin was found to be free of apoproteins by immunochemical assay using antisera to the CI, CII T'he influence ofthe apoprotei n ineubatiodn son the em ulsion characteristics was evaluated by sucXrose dlensitv gradient centrifuigation (16) . The lipid dlispersioims were also suibjecteul to agarose electrophoresis by a staim(lard miiethodl (17) . The plhospholipidl audI triglyceride conitenits of the pre-anid postincubation emniulsioni and chylomnicrons were dletermined by stan(lard methods (18, 19 (20) . The perfuisate wvas Krebs-Ringer bicarboniate buffer prepare(d so that the calciumll concentrationi varied between 8.5 and( 10 mg/dl, and containecl 3 g of bovine albumin/100 mill free of all C and E apoproteins when assayed by Ochterlony immiiunodiffusion, using antisera preparedf in rabbits to each apoprotein, an(l by SDS polvacrvlamide gel electrophoresis (13) . Oxygenation of the rotatinig reservoir conitaillitng 250 ml buffer was prodluced with 95% 02, 5% CO2. The rat liver was perfuise(d by initially canniulatinig the portal vein, ligating the hepatic artery anid promptly cannllulatinig the vena cava. Approximately 100 mll of vashout was put through the liver before the emulsioni was infused. It was determined that <50 Cm13 was actually necessary to free the effluenit perfusate of any residual apoproteini. After the 100-ml washouit was completed, the triglyceride emulllsioni (2 mg/10 ml) was infuised at a conistant rate for 5 min. The flov rates averaged between 1.0 adl( 1.2 ml/g per min. Bile volumes (hiiring the 20 min of these perfmisionts averaged 0.3 ml. The serumii glutamiiate pyruvate transaminitase contents of the effluenit were lowv anid the histology was normal. The nonireeveling perfiusate was collectedl at 1-mmii intervals and(l after the infusion was terminiated a 50-mIii washout wvas performeld. No fuirther activity was eluted from the hepatic bed after this volume ofwashout. The effluenit perfuisate was immllerse(d in ice andI the liver was weighecl andcl also placed in ice within 1 mini after the (lisconitinuiatioll of the perfusioni. Ani aliquot of somiie of the livers fromii these studies was frozeni or formiialini-fixe(d for radioautography. The radioautography w as performiied by a standar(d approachl (21).
Cheica11eil isolation. 4 ml of the effluent perfusate anid 1ml of the injection soluitioni were extracted by the Dole metho(d (22) . Ani aliqutot of these lipidl extracts was counite(d in a liqjuid scintillationi spectromieter (Intertechi i(quie miio(lel S L-4000) lnd(ler double labeled coniditions. Aniother aliqtuot of the heptanie phase wvas chromlatographed on a neuitral lipi(d thin layer sy1stem anid each lipid banid assayed for radioactivity. After it was established that >85% of both labels was in the triglyceride hand, the extract was used without chromlatographv. After the perfusioni wvashout, the livers were weighed and homogenize(d anid extracted by either a Folch (23) or a Dole (22) mletho(l. Ali(quots of the lipid phase were chrom1atographed on a nieuitral lipid thini layer svstem to (letermine the distribution of lipid radioactivity. Because >90% of the hepatic radioactivity wvas triglyceride, the lipid phase was counlte(d directly in the later experimenits. Radioactivity vas assayed uncler (louble labeled condlitions aund both 3H and 14C internial stan(lards wvere added to the hepatic samiiples to correct for quienching.
RESULTS
The incubationi of the 125I-labeled E apoproteini with synthetic emnulsioins at conceintrations <5% of the total lipid weight prodcuce(d aIn E protein content ofthe emnilsion ranginig fromii 7 to 20 ,g/mg total lipi(l. Chylonlicron incubations with pure apo E protein at 10% of the total lipi(d content produced a similar miean ineremiient in E ie patic Triglyceride Uptake aC1d C1mi1lom icron1 Apo protein Conltent 65 protein (12 Ag/mg chylo lipid). This increment in protein after E apoprotein incubations produced no change in the chylomicron radioactivity distribution on a sucrose density gradient. The lipid content, electrophoretic mobility, and electron microscopic appearance of the recovered chylomicrons were no different for buffer and E protein incubations. Incubations ofthe synthetic emulsions with Apo E ratios higher than those used here (>7.5%) produced dramatic changes in emulsion appearance and properties,2 but this was not seen at these lower concentrations.
When the E apoprotein was incubated with these emulsions together with individual C proteins at double the E concentration, a decrease in the amount of E protein on the recovered emulsion was noted. The CI protein incubations produced an E-protein content that was 83% of those incubations without C proteins. A decrease to 70% was noted for the CII protein and to 81% for the CIII-1. The estimated mean incorporations of these proteins on the emulsion when incubated at twice the E concentration were: CI, 40 Ag/lmg; CII, 26 ug/mg; CIII-1, 28 ,g/mg total emulsion lipid. The same data for chylomicrons were: CI, 48 pldmg; CII, 34 Ag/lmg; CIII-1, 38 ,ug/mg total chylomicroni lipid.
The SDS polyacrylamide pattern for the synthetic emulsion showed selective increments of the Apo E and C proteins after incubation with these apoproteins (Fig. 1) (Fig. 2) . We have noted2 that Apo E can change the sucrose density distribution of synthetic emulsions when high concentrations of apoprotein (>7.5% of the emulsion mass) are employed. To normalize the emulsions for any potential size effect, we harvested similar sized particles from the sucrose density gradients (24) of control and Apo E emulsions and investigated their hepatic uptake. The same differences were observed for the more homogeneously sized emulsions as were seen for the entire preparation.
When rat mesenteric lymph chylomicrons were incubated with the purified human Apo E protein, results quite similar to that observed for the in vitro prepared emulsion were observed (Table I) Signiificant at the P < 0.5 level. § Significant at the P < 0.01 level. "Significant at the P < 0.001 level.
FIGURE 2 A radio-autograph of the frozen section of a liver perfused with a synthetic [3H]triglyceride emulsion containing Apo E. The liver was processed by the method of Stein and Stein (21) are developed at a magnification of 400. The dark granules are the developed radioactivity. pared with the conitrol. A four-to fivefol(d greater recoverv of the triglyceride labels was observed in those livers perfuse(d with the Apo E eniriche(d chylomicrons. Again, the labels were recovered in the samiie ratio as they had been injected, andl >90% of the activity was in hepatic triglyceride, simiiilar to the radioactivity distribution on the infuise(d chylomnicron.
XVheni the chvlomicronis enter plasmiia, it has been notecl that thev are enriched in Apo E as well as Apo C (25, 26) . Plasma-exposedl rat mesenteric lymllph chylomicrons were also evaluatedl in terms of their clearance by the liver on1 a single pass perfusioni at similar inflow rates (400 ,ug triglyceride/mmiill). Rat plasmaincubated chylomicrons that demonstratedl the previously describedl apoprotein alterations (25) revealed no significant differences (Table I) wlheni compared with the control lymph chylomicron, despite a considerable enrichm-ient in Apo E. These Apo E-enriched chylomicronis were also enriched in the C proteins, suggestinig the possibility that one or a combination of the proteins modified the Apo E effect.
The three human C proteins CI, CII, and CIII were tested as to their influenice on the hepatic removal of lipid emulsions. These emulsions and chylomicrons were exposed to 2:1 ratios of C:E in an attempt to approximate their relative contents in human very low density lipoprotein (27) . The CI and CII proteins did not appear to affect the increased hepatic uptake of either the synthetic emulsion or chylomicron produced by the Apo E protein (Table II) . The CIII protein that was pure CIII-1 by urea polyacrylamide gel electrophoresis (14) had a pronounced inhibitory effect oni the hepatic uptake of both the synthetic emuilsion and the lymph chylomicrons that had been loaded with Apo Hepatic Triglyceride Uptake atnd Chri loinicron Apoprotein Coiltent Apo E 58 (9) 62 (11) 24 (2) 27 (4) Apo E and CI 55 (9) 59 (7) 27 (7) 28 (8) Apo E and CII 64 (5) 69 (5) 22 (5) 21(4) Apo E and CIII 88 (4) 89 (5) 6 (3) 7 (3) * The infused emulsions and chylomicrons contained a 3H in the glycerol moiety and a 14C in the fatty acid of the glyceride. Each datum represents the mean of four determinations; two with the emulsions and two with the chylomicrons. The standard errors are within the parentheses.
E protein (Table II) . Further studies of the addition of CIII protein to lymph chylomicrons (Table III) revealed a marked inhibition of hepatic uptake of chylomicron glyceride. This was observed both in comparisons of Apo E-loaded chylomicrons with and without CIII, and in comparisons of the control chylomicron with the CIII-loaded particle (Table III) . Although the CIII protein decreased the amount of Apo E on the emulsion when compared with the E-incubated dispersion alone, both CI and CII had similar if not greater effects on the emulsion content of Apo E, but neither significantly influenced hepatic uptake. None of the C apoproteins altered the lipid composition or gross physical characteristics of the E-loaded chylomicron or emulsion. Incubations of chylomicrons with CIII concentrations one half that of the Apo E still inhibited the hepatic removal of chylomicrons (Table   IV) when compared with the Apo E-loaded particle, but not to the same extent as the higher concentrations.
DISCUSSION
After the in vivo injection of lymph chylomicrons in rats appreciable amounts ofchylomicron triglyceride (-20%) and virtually all of the sterol was recovered in the liver (28) . Most of the chylomicron triglyceride was distributed to peripheral tissues. Studies with doublelabeled chylomicron triglyceride showed initial hepatic uptake of unhydrolyzed triglyceride whereas uptake in the periphery required hydrolysis (28) . Several investigators (1) have suggested that no chylomicron triglyceride has direct access to the liver and only chylomicron triglyceride that has previously been metabolized at the periphery is subsequently recovered in the liver. Even though controversy surrounds the quantitative significance of the hepatic clearance of lymph chylomicrons, a consensus appears to exist on the ready hepatic uptake of chylomicron remnants (6, 29, 30) . The remnant differs from the lymph chylomicron not only in its lesser content of triglyceride and increment in cholesterol ester, but its apoprotein pattern as well. The remnant is enriched in the Apo E protein (7) and probably has less C protein than does the lymph chylomicron that gains these proteins upon entry into plasma (26) . The molecular basis for the apparently more avid hepatic uptake ofthe remnant than the lymph chylomicron is unknown. It has been suggested that an interaction of a hepatic receptor with possibly the remnant E protein may facilitate the uptake of this particle (29) . However, the lymph chylomicron entering the plasma becomes appreciably enriched in Apo E and if this were the major mechanism responsible for uptake, the triglyceride of these particles should be predominantly t Significantly different from control at P < 0.001. § Significantly different from control at P < 0.01.
"Significanitly different from control at P < 0.02. (31) . If the hepatic uptake of chylomicron lipid is importantly influenced by the content of these two apoproteins, the amount of the two high density lipoproteins may importantly influence the partition of the lipid between the liver and periphery. The triglyceride rich very low density lipoproteins emerging from the liver contain both E and C protein (32) with probable increments of both upon entering plasma. If CIII were not present on these E containing triglyceride-rich lipoproteins, an ineffectual recycling to the liver might result. The observation that at least two apoproteins control hepatic uptake provides a mechanism for denying these lipoproteins hepatic access until appropriate peripheral metabolism has occurred at which point retrieval occurs. These issues are presently speculative, and need further experimental development. The lack of accurate measurements of the lymph chylomicron apoproteins (AI and AIV) in the present study cloud the interpretation of the chylomicron data. A more sensitive assay system needs to be employed to evaluate the influence of these apoproteins on hepatic retrieval.
The ability of the E protein to increase the hepatic uptake of both the chylomicron and synthetic emulsion may be on the basis of the apoproteins' known affinity for glycosaminoglycans. Previous studies (11) of very low density lipoproteins containing considerable quantities of both Apo E and CIII reveal an intact heparin affinity. Preliminary data2 have defined an influence of E protein on emulsion properties other than heparin affinity which CIII appears to counteract. However, despite the possibility of considerable glycosaminoglycan contents in the space of Disse (33) other mechanisms may determine the hepatic uptake of these lipoproteins. The previous work of Higgins (34) and these data also make it doubtful that an Apo E hepatocyte receptor simiiilar to that on the fibroblast (35) (37) . If insufficient CIII were available in plasma or improperly distributed on lipoproteins, the inhibitory effect may be blunted and enhanced hepatic lipid deposits anticipated.
